These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30954610)

  • 1. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
    Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N
    Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States.
    Shelton JB; Paivanas TA; Buffington P; Ruyle SR; Cohen ES; Natale R; Mehlhaff B; Suh R; Bradford TJ; Koo AS; Kwan L; Shore N
    Urology; 2019 Aug; 130():72-78. PubMed ID: 31029668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
    Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
    J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice-Level Adoption of Conservative Management for Prostate Cancer.
    Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
    J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.
    Auffenberg GB; Lane BR; Linsell S; Cher ML; Miller DC
    JAMA Surg; 2017 Oct; 152(10):978-980. PubMed ID: 28636713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices.
    Freedland SJ; Richhariya A; Wang H; Chung K; Shore ND
    Urology; 2012 Aug; 80(2):293-8. PubMed ID: 22748612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
    Mitchell JM; Gresenz CR
    Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care delivery system contributions to management of newly diagnosed prostate cancer.
    Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Pathological Outcomes for Men with Low Risk Prostate Cancer from Diverse Practice Settings: Similar Results from Immediate Prostatectomy or Initial Surveillance with Delayed Prostatectomy.
    Auffenberg GB; Linsell S; Dhir A; Myers SN; Rosenberg B; Miller DC;
    J Urol; 2016 Nov; 196(5):1415-1421. PubMed ID: 27256204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities.
    Agochukwu-Mmonu N; Qin Y; Kaufman S; Oerline M; Vince R; Makarov D; Caram MV; Chapman C; Ravenell J; Hollenbeck BK; Skolarus TA
    JCO Oncol Pract; 2023 May; 19(5):e763-e772. PubMed ID: 36657098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Performance of Active Surveillance Selection Criteria in Diverse Urology Practices.
    Hawken SR; Womble PR; Herrel LA; Ye Z; Linsell SM; Hurley PM; Montie JE; Miller DC;
    J Urol; 2015 Nov; 194(5):1253-7. PubMed ID: 25981805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Gaylis F; Cohen E; Calabrese R; Prime H; Dato P; Kane CJ
    Urology; 2016 Jul; 93():60-7. PubMed ID: 26876460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.